NCT01758653

Carbon Monoxide Blood and DNA Biorepository

Carbon Monoxide Blood and DNA Repository

• Status: Enrolling By Invitation
• Phase: —
• Study type: Observational
• Enrollment: 300 (estimated)
• Sponsor: Intermountain Health Care, Inc. · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this biorepository is to collect blood from patients at the time of CO poisoning and at follow-up visits months to years later. These samples can be used in the future to learn more about how CO damages the heart and brain and whether blood tests could predict which patients will have problems after CO poisoning.

Detailed description

The investigators propose to establish a biorepository for storage of serum, plasma, and DNA collected from patients with carbon monoxide (CO) poisoning. Participants will also be evaluated for clinical outcome. The biorepository will include serum and plasma from CO-poisoned patients drawn at the time of injury as well as from blood drawn at clinical follow-up visits. The biorepository will also bank DNA from these participants. These specimens can be analyzed in the future to elucidate potential inflammatory and immunological mechanisms that cause brain and heart damage and identify possible biological and genetic predictors of poor outcome.

Conditions

• Carbon Monoxide Poisoning

Interventions

Type	Name	Description
OTHER	No study intervention	There is no study-related intervention.

Timeline

• Start date: 2012-02-01
• Primary completion: 2032-12-01
• Completion: 2032-12-01
• First posted: 2013-01-01
• Last updated: 2023-09-29

Locations

2 sites across 1 country: United States